// App-Quantinova.ai

[AB0475] : BIOLOGICS IN MONOTHERAPY IN RHEUMATOID ARTHRITIS: A MULTICENTRIC RESTROSPECTIVE STUDY OF 109 PATIENTS

Researchers

Presenter

  • N. Rahal

Principal Investigators

  • N. Afif

  • M. Ardizzone

  • L. Sparsa

  • M. Schaeffer

  • L. Messer

  • P. Moreau

  • J. Sibilia

  • C. Sordet

Medical Centers

  • Hopital Pasteur, Colmar, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Rheumatoid arthritis

  • Solid malignancies

  • Anemia, sideroblastic, spinocerebellar ataxia

Biomarkers

  • anti-CCP antibodies

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Tocilizumab

  • Infliximab

  • FA-8

  • Hydroxyzine

  • Abatacept

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim